ClinicalTrials.gg
RecruitingNCT07941648Updated Nov 17, 2026

Combined Treatments for Somatosensory Tinnitus

An interventional study of Mindfulness and Counseling in Somatosensory Tinnitus, sponsored by Universidade Federal de Santa Maria. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Universidade Federal de Santa Maria · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jan 2025, registered Nov 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 21 studies in Tinnitus with a site in Brazil — 2 open to participants now, 3 under way, none of them phase 3. Tinnitus · Brazil.

Planned enrollment
9th of 17
52 · median 52
Started
2025
the only one that year
No phase
11 of 21
2 open now
Registered
21st of 21
by date
Lead sponsor
2 of 21
Universidade Federal de Santa Maria

Among the 21 studies in Tinnitus with a site in Brazil, this one is the 9th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2025, is one of 11 with no phase, and was the 21st registered.

Tinnitus

444 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

Browse Tinnitus studies →

Open to participants now

2 of the 21 studies in Tinnitus with a site in Brazil are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Tinnitus with a site in Brazil, or all of them as a file.
02

Study summary

The purpose of this clinical trial is to evaluate whether a combination of manual therapies, therapeutic exercises, and integrative and complementary practices reduces the loudness, discomfort, and impact of somatosensory tinnitus. This type of tinnitus is associated with changes in the neck and/or jaw joint.

The main questions this study aims to answer are:

Does the combined treatment reduce tinnitus loudness, discomfort, and impact more than placebo?

Are the benefits maintained three months after treatment ends?

Researchers will compare two groups: one will receive the combined treatment targeting the neck and jaw regions, and the other will receive simulated procedures (placebo) that resemble the treatment procedures.

Participants will:

Attend one session per week for 12 weeks (three months), receiving either the combined treatment or placebo, depending on the group to which they are randomly assigned.

Complete questionnaires before and at the end of the 12 weeks.

Return for a follow-up assessment three months after the sessions end to determine whether the effects have been maintained.

Read the detailed description

Somatosensory tinnitus is a form of tinnitus in which sensory input from the neck or jaw can influence the perceived sound. In some individuals, tinnitus changes during neck or jaw movements or in response to pressure on specific muscles. The clinical rationale for this trial is to address these musculoskeletal factors alongside the burden of tinnitus in daily life.

The treatment program combines manual therapies, therapeutic exercise, and integrative and complementary practices. These approaches were selected to address different aspects of the condition within the same program, including muscle tension, movement and function of the neck and jaw, and how participants respond to tinnitus. The study hypothesis is that these complementary approaches may provide greater benefit when delivered as a combined program than the simulated procedures used as the placebo control.

This placebo-controlled clinical trial will compare the effects of the combined program and the simulated procedures in adults with somatosensory tinnitus. The study will evaluate changes in perceived tinnitus loudness, tinnitus-related bothersomeness, and the impact of tinnitus on daily life. Follow-up will assess whether any improvements observed at the end of treatment are maintained.

03

Conditions studied

  • Somatosensory Tinnitus

Keywords

  • tinnitus
  • Clinical Protocols
  • Complementary Therapies
  • Exercise Movement Techniques
  • Myofascial Pain Syndromes
  • Combined Modality Therapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants of either sex;
  • Aged 18 years or older;
  • Normal hearing thresholds or sensorineural hearing loss up to severe degree, provided that participants can understand verbal instructions and mindfulness recordings;
  • Positive screening for somatosensory tinnitus;
  • Presence of one or more active or latent myofascial trigger points in the head, neck, and/or shoulder girdle;
  • A Visual Analog Scale (VAS) score greater than 5 for tinnitus-related discomfort or perceived tinnitus loudness.

Exclusion criteria

Exclusion Criteria:

  • Physical therapy for tinnitus, temporomandibular disorders, or neck pain within the 30 days preceding the assessment;
  • Ongoing treatment using any of the techniques proposed in the study;
  • Positive screening for vascular tinnitus;
  • A diagnosed ear, nose, or throat condition underlying the tinnitus;
  • Neurological conditions potentially causing tinnitus;
  • Inability to read, understand, and complete the questionnaires or to understand and follow instructions, for example, due to illiteracy, dementia, or blindness;

Fibromyalgia;

Previous negative experiences with needles used for therapeutic purposes;

A formal to dry needling, such as chronic anticoagulant use or hematological disorders;

Altered sensation.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    G1-Combined Treatment

    Participants will receive 12 weekly sessions over three months. During the first month, treatment will combine mindfulness and myofascial release. During the second month, treatment will combine mindfulness and Pilates exercises. During the third month, treatment will combine auriculotherapy and dry needling. The physical interventions will target the cervical and temporomandibular regions.

    Behavioral: Mindfulness · Behavioral: Counseling · Procedure: Myofascial release · Procedure: Pilates · Procedure: Auriculotherapy · Procedure: Dry Needling

  • Placebo comparator
    G2- Sham Treatment

    Participants will receive 12 weekly sessions over three months. During the first month, they will listen to relaxation recordings matched in duration to the mindfulness practices in the intervention group and receive manual manipulation without trigger point deactivation techniques. During the second month, they will listen to the same types of recordings and perform gentle, unloaded movements, including upper limb, lower limb, and spinal stretching. During the third month, they will receive microporous adhesive tape applied to the ear without stimulation of auricular points and superficial skin needling in the abdominal, quadriceps, and gastrocnemius regions.

    Behavioral: Relaxation Audio Recordings · Procedure: Manual Manipulation Without Trigger Point Deactivation · Procedure: Gentle Movements and Stretching · Procedure: Auricular Tape Application Without Stimulation · Procedure: Superficial Skin Needling

Interventions

  • BehavioralMindfulness

    This intervention is part of the G1 intervention group and consists of seven sessions using guided mindfulness recordings. Participants will be instructed to practice once daily. The recordings will be replaced weekly and sent via WhatsApp. Each recording lasts between 3 and 15 minutes.

  • BehavioralCounseling

    Counseling is part of the G1 intervention and will be delivered individually during the first session, lasting 15 minutes. Guidance will be tailored to each participant's needs to encourage adherence to the proposed practices and changes in behaviors and lifestyle habits that may contribute to worsening tinnitus.

  • ProcedureMyofascial release

    Myofascial release is part of the G1 intervention and will be delivered in four sessions. Myofascial trigger points will be treated using gradually increasing, sustained digital pressure until the participant reports no tenderness at the site, followed by manual techniques along the taut muscle band. Target muscles will include the infraspinatus, levator scapulae, upper trapezius, splenius capitis, splenius cervicis, sternal head of the sternocleidomastoid, superficial masseter, anterior temporalis, and lateral and medial pterygoids. Myofascial release will last 30 minutes during the first session, which will also include counseling and an introduction to mindfulness. Each of the remaining three sessions will include 40 minutes of myofascial release.

  • ProcedurePilates

    Pilates is part of the G1 intervention and will be delivered during the second month of treatment, comprising four weekly 40 minutes sessions at the tinnitus outpatient clinic. Mat-based exercises will use a mat, a small exercise ball, and 1-kg dumbbells, with adaptations for individuals with tinnitus, neck pain, and muscle tension. Each exercise will be performed in one set of 10, 15, or 20 repetitions, adjusted to the participant's fitness level and reported pain and fatigue. Sessions will include preparatory pre-Pilates and breathing exercises, basic exercises incorporating Pilates principles, and final stretching. Participants with temporomandibular disorders will also receive specific temporomandibular joint exercises and instructions to perform them at home once daily until the end of treatment.

  • ProcedureAuriculotherapy

    Auriculotherapy is part of the G1 intervention and will be delivered during the third month of treatment in four weekly 10-minute sessions. Auricular points will be selected based on Traditional Chinese Medicine and previous studies addressing tinnitus and muscle tension in the cervical, thoracic, and temporomandibular regions. Mustard seeds will be secured to the ear with microporous adhesive tape, alternating between the right and left ears each week. Participants will be instructed to keep the seeds in place for up to three days and press each auricular point 15 times, at least three times daily.

  • ProcedureDry Needling

    Dry needling is part of the G1 intervention and will be delivered during the third month of treatment in four weekly sessions alongside auriculotherapy. Sterile, single-use, disposable acupuncture needles measuring 0.20 × 30 mm (DUX) will be used. The therapist will wear gloves, and the skin will be disinfected with 70% w/w alcohol. Participants will be positioned supine for needling of the upper trapezius, sternocleidomastoid, masseter, and lateral pterygoid; prone for the upper trapezius and infraspinatus; and side-lying for the splenius capitis, splenius cervicis, and levator scapulae.

  • BehavioralRelaxation Audio Recordings

    This intervention is part of the G2 control group and consists of listening to relaxation recordings selected from YouTube during the first and second months of treatment. The recordings will be matched in duration to the mindfulness practices used in the G1 intervention group. Participants will be instructed to listen once daily. The recordings will be replaced weekly and sent via WhatsApp.

  • ProcedureManual Manipulation Without Trigger Point Deactivation

    This intervention is part of the G2 control group and will be delivered during the first month of treatment in four weekly sessions. Participants will receive manual manipulation without myofascial trigger point deactivation techniques. Session duration will match that of myofascial release in G1: 30 minutes in the first session and 40 minutes in each of the remaining three sessions.

  • ProcedureGentle Movements and Stretching

    This intervention is part of the G2 control group and will be delivered during the second month of treatment in four weekly 40 minutes sessions. Participants will perform gentle, unloaded movements, including upper limb, lower limb, and spinal stretching, as a comparison intervention to the Pilates exercises performed by the G1 group.

  • ProcedureAuricular Tape Application Without Stimulation

    This intervention is part of the G2 control group and will be delivered during the third month of treatment in four weekly sessions. Microporous adhesive tape will be applied to the ear without seeds or stimulation of auricular points, as a sham comparison to auriculotherapy in the G1 group.

  • ProcedureSuperficial Skin Needling

    This intervention is part of the G2 control group and will be delivered during the third month of treatment in four weekly sessions, alongside auricular tape application without stimulation. Participants will receive superficial skin needling in the abdominal, quadriceps, and gastrocnemius regions as a comparison procedure to dry needling in the G1 group.

06

What researchers measure

Primary outcomes

  1. Change in Tinnitus Discomfort Visual Analog Scale Score

    Tinnitus-related discomfort will be assessed using a visual analog scale (VAS) ranging from 0 to 10. Higher scores indicate greater discomfort. A decrease in score from baseline indicates improvement.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

  2. Change in Tinnitus Loudness Visual Analog Scale Score

    Perceived tinnitus loudness will be rated on a visual analog scale ranging from 0 to 10. Higher scores indicate greater perceived loudness. A reduction from baseline indicates improvement.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

  3. Change in Tinnitus Handicap Inventory Total Score

    Handicap Inventory Total Score The 25-item Tinnitus Handicap Inventory will assess tinnitus-related handicap. Total scores range from 0 to 100, with higher scores indicating greater handicap. A reduction from baseline indicates improvement.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

  4. Change in Tinnitus Functional Index Total Score

    The 25-item Tinnitus Functional Index will assess tinnitus severity and functional impact. Total scores range from 0 to 100, with higher scores indicating greater impact. A reduction from baseline indicates improvement.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

  5. Change in Hospital Anxiety and Depression Scale Anxiety and Depression Subscale Scores

    Anxiety and depressive symptoms will be assessed using the Hospital Anxiety and Depression Scale (HADS), a 14-item questionnaire comprising two seven-item subscales. Each subscale ranges from 0 to 21, with higher scores indicating more severe symptoms. Changes from baseline will be assessed separately for anxiety and depression.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

Secondary outcomes

  1. Change in Neck Disability Index Total Score

    Neck-related disability will be assessed using the 10-item Neck Disability Index. Raw total scores range from 0 to 50, with higher scores indicating greater disability. A reduction from baseline indicates improvement.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

  2. Change in Maximum Skin Temperature Assessed by Infrared Thermography

    Maximum skin temperature, in degrees Celsius (°C), will be assessed using infrared thermography over the surface regions corresponding to the infraspinatus, levator scapulae, upper trapezius, splenius capitis, splenius cervicis, sternal head of the sternocleidomastoid, superficial masseter, and anterior temporalis. Images will be acquired with participants standing, using anterior, posterior, and lateral views to evaluate temperature changes following treatment.

    Time frame: Baseline, immediately after completion of the 12-week treatment, and three months after treatment completion.

07

Study locations

1 of 1 sites recruiting
  • Federal University of Santa Maria - Speech-Language Pathology and Audiology Service
    Santa Maria, Rio Grande do Sul 97105-900, Brazil
    Recruiting
08

References and documents

Publications

  • Yu S, Wu J, Sun Y, Lyu J. Advances in acupuncture treatment for tinnitus. Am J Otolaryngol. 2024 May-Jun;45(3):104215. doi: 10.1016/j.amjoto.2024.104215. Epub 2024 Jan 5. PubMed 38218028 ↗
  • Xu A, Huang Q, Rong J, Wu X, Deng M, Ji L. Effectiveness of ischemic compression on myofascial trigger points in relieving neck pain: A systematic review and meta-analysis. J Back Musculoskelet Rehabil. 2023;36(4):783-798. doi: 10.3233/BMR-220045. PubMed 36872769 ↗
  • Wasano K, Kawasaki T, Goto F, Hiraga Y, Nagai S, Tominaga M, Ogawa K. Mobile Application as a Digital Therapeutic for Chronic Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026 Jul 1;152(7):677-685. doi: 10.1001/jamaoto.2026.0858. PubMed 42096236 ↗
  • Trochidis I, Lugo A, Borroni E, Cederroth CR, Cima R, Kikidis D, Langguth B, Schlee W, Gallus S. Systematic Review on Healthcare and Societal Costs of Tinnitus. Int J Environ Res Public Health. 2021 Jun 26;18(13):6881. doi: 10.3390/ijerph18136881. PubMed 34206904 ↗
  • Tariq M, Fatima K, Khan SFA, Mahmood W, Mahmood T, Khurshaid S, Khalid M, Khoosa M, Babur MN. Efficacy of massage versus massage with post isometric relaxation in temporomandibular disorders: a randomized controlled trial. BMC Sports Sci Med Rehabil. 2024 May 16;16(1):110. doi: 10.1186/s13102-024-00865-x. PubMed 38750518 ↗
  • Soylemez E, Apaydin AS, Aydogan Z, Sen NH, Yasar M, Argadal OG. Comparative Analysis of the Efficacy of Transcutaneous Electrical Nerve Stimulation in Somatic and Idiopathic Tinnitus Patients. Brain Behav. 2025 Mar;15(3):e70429. doi: 10.1002/brb3.70429. PubMed 40103239 ↗
  • de Souza Junior EF, Pereira CMV, Barbosa JDS, Arruda MJALLA, Pita de Melo D, Bento PM. Hypervigilance to pain and sleep quality are confounding variables in the infrared thermography examination of the temporomandibular joint and temporal and masseter muscles. Dentomaxillofac Radiol. 2024 Oct 1;53(7):478-487. doi: 10.1093/dmfr/twae032. PubMed 38991840 ↗
  • Skorupska E, Dybek T, Rychlik M, Jokiel M, Dobrakowski P. The Automatization of a New Thermography Method Using Invasive Nociceptive Stimulation to Confirm an Autonomic Phenomenon within a Trigger Point Referred Pain Zone. Brain Sci. 2021 Jul 6;11(7):893. doi: 10.3390/brainsci11070893. PubMed 34356127 ↗
  • Sanchez TG, Rocha CB. Diagnosis and management of somatosensory tinnitus: review article. Clinics (Sao Paulo). 2011;66(6):1089-94. doi: 10.1590/s1807-59322011000600028. PubMed 21808880 ↗
  • Roggio F, Petrigna L, Filetti V, Vitale E, Rapisarda V, Musumeci G. Infrared thermography for the evaluation of adolescent and juvenile idiopathic scoliosis: A systematic review. J Therm Biol. 2023 Apr;113:103524. doi: 10.1016/j.jtherbio.2023.103524. Epub 2023 Feb 17. PubMed 37055128 ↗
  • Rocha CB, Sanchez TG. Efficacy of myofascial trigger point deactivation for tinnitus control. Braz J Otorhinolaryngol. 2012 Dec;78(6):21-6. doi: 10.5935/1808-8694.20120028. PubMed 23306563 ↗
  • De Ridder D, Vanneste S, Song JJ, Adhia D. Tinnitus and the Triple Network Model: A Perspective. Clin Exp Otorhinolaryngol. 2022 Aug;15(3):205-212. doi: 10.21053/ceo.2022.00815. Epub 2022 Jul 11. PubMed 35835548 ↗
  • Pandey P, Knoetze M, Sharma A, Swanepoel W, Manchaiah V. Efficacy of Single-Session Intervention of Tinnitus Educational Counseling: A Systematic Review. Am J Audiol. 2026 Mar 5;35(1):378-388. doi: 10.1044/2025_AJA-25-00120. Epub 2026 Feb 5. PubMed 41642082 ↗
  • Moura CC, Chaves ECL, Chianca TCM, Ruginsk SG, Nogueira DA, Iunes DH. Effects of auricular acupuncture on chronic pain in people with back musculoskeletal disorders: a randomized clinical trial. Rev Esc Enferm USP. 2019 Jan 21;53:e03418. doi: 10.1590/S1980-220X2018009003418. English, Portuguese. PubMed 30673051 ↗
  • Moreira HG, Garcia MV. Clinical investigation protocol for tinnitus (CIP-t): development and validation of an instrument. Codas. 2026 Apr 27;38(3):e20250125. doi: 10.1590/2317-1782/e20250125pt. eCollection 2026. PubMed 42054183 ↗
  • Morais BX, Munhoz OL, Moreira CHC, Kurebayashi LFS, Lopes LFD, Magnago TSBS. Auriculotherapy for reducing chronic spinal pain in health workers: a clinical trial. Rev Lat Am Enfermagem. 2023 Jun 19;31:e3953. doi: 10.1590/1518-8345.6641.3953. eCollection 2023. PubMed 37341260 ↗
  • Michiels S. Somatosensory Tinnitus: Recent Developments in Diagnosis and Treatment. J Assoc Res Otolaryngol. 2023 Oct;24(5):465-472. doi: 10.1007/s10162-023-00912-3. Epub 2023 Oct 4. PubMed 37794291 ↗
  • De Meulemeester K, Meeus M, De Pauw R, Cagnie B, Keppler H, Lenoir D. Suffering from chronic tinnitus, chronic neck pain, or both: Does it impact the presence of signs and symptoms of central sensitization? PLoS One. 2023 Aug 24;18(8):e0290116. doi: 10.1371/journal.pone.0290116. eCollection 2023. PubMed 37616265 ↗
  • Meikle MB, Henry JA, Griest SE, Stewart BJ, Abrams HB, McArdle R, Myers PJ, Newman CW, Sandridge S, Turk DC, Folmer RL, Frederick EJ, House JW, Jacobson GP, Kinney SE, Martin WH, Nagler SM, Reich GE, Searchfield G, Sweetow R, Vernon JA. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear. 2012 Mar-Apr;33(2):153-76. doi: 10.1097/AUD.0b013e31822f67c0. PubMed 22156949 ↗
  • Macedo CF, Sonza A, Puel AN, Santos ARD. Trigger point dry needling increases masseter muscle oxygenation in patients with temporomandibular disorder. J Appl Oral Sci. 2023 Aug 25;31:e20230099. doi: 10.1590/1678-7757-2023-0099. eCollection 2023. PubMed 37646716 ↗
  • Liu Q, Li M, Wang W, Jin S, Piao H, Jiang Y, Li N, Yao H. Infrared thermography in clinical practice: a literature review. Eur J Med Res. 2025 Jan 16;30(1):33. doi: 10.1186/s40001-025-02278-z. PubMed 39815375 ↗
  • Korelo RIG, Moreira NB, Miguel BAC, Cruz CGD, Souza NSP, Macedo RMB, Gallo RBS. Effects of Auriculotherapy on treatment of women with premenstrual syndrome symptoms: A randomized, placebo-controlled clinical trial. Complement Ther Med. 2022 Jun;66:102816. doi: 10.1016/j.ctim.2022.102816. Epub 2022 Feb 12. PubMed 35167949 ↗
  • Juan YH, Hsu CT, Hwang JH. Outcomes of Triple-Combination Therapy for Chronic Tinnitus. In Vivo. 2019 Sep-Oct;33(5):1707-1712. doi: 10.21873/invivo.11660. PubMed 31471428 ↗
  • Jiang Y, Liu Q, Ding Y, Sun Y. Systematic review and meta-analysis of the correlation between tinnitus and mental health. Am J Otolaryngol. 2025 May-Jun;46(3):104611. doi: 10.1016/j.amjoto.2025.104611. Epub 2025 Mar 11. PubMed 40088765 ↗
  • Jarach CM, Karydou K, Trochidis I, Bernal-Robledano A, van den Brandt PA, Cima R, Cederroth CR, Lopez-Escamez JA, Ghislandi S, Hall DA, Kikidis D, Langguth B, Lugo A, Mazurek B, Odone A, Schecklmann M, Schoisswohl S, Simoes JP, Schlee W, Gallus S. The Out-of-pocket Expenses of People With Tinnitus in Europe. J Epidemiol. 2024 Nov 5;34(11):515-525. doi: 10.2188/jea.JE20230358. Epub 2024 May 25. PubMed 38797674 ↗
  • Jarach CM, Lugo A, Scala M, van den Brandt PA, Cederroth CR, Odone A, Garavello W, Schlee W, Langguth B, Gallus S. Global Prevalence and Incidence of Tinnitus: A Systematic Review and Meta-analysis. JAMA Neurol. 2022 Sep 1;79(9):888-900. doi: 10.1001/jamaneurol.2022.2189. PubMed 35939312 ↗
  • Hong G. Somatosensory Stimulation Therapy in Patients with Somatosensory Tinnitus: A Pilot Study. Otol Neurotol. 2023 Jun 1;44(5):418-424. doi: 10.1097/MAO.0000000000003878. Epub 2023 Apr 16. PubMed 37072915 ↗
  • FIGUEIREDO, R. R.; AZEVEDO, A. A. de; OLIVEIRA, P. de M. Análise da correlação entre a escala visual-análoga e o Tinnitus Handicap Inventory na avaliação de pacientes com zumbido. Revista Brasileira de Otorrinolaringologia, São Paulo, v. 75, n. 1, p. 76-79, 2009.
  • Ferreira RO, Dos Santos VRN, Matos Sousa JM, Peinado BRR, Souza-Monteiro D, Bittencourt LO, Lima MLS, Rosing CK, Mezzomo Collares F, Antunes de Araujo A, Lima RR. Physical training minimizes immunological dysfunction, oxidative stress and tissue destruction on experimental periodontitis in rats. PLoS One. 2024 Jun 6;19(6):e0303374. doi: 10.1371/journal.pone.0303374. eCollection 2024. PubMed 38843156 ↗
  • Paula Erika Alves F, Cunha F, Onishi ET, Branco-Barreiro FC, Gananca FF. [Tinnitus Handicap Inventory: cross-cultural adaptation to Brazilian Portuguese]. Pro Fono. 2005 Apr-Dec;17(3):303-10. doi: 10.1590/s0104-56872005000300004. Portuguese. PubMed 16389787 ↗
  • Fernandez-Hernando D, Fernandez-de-Las-Penas C, Machado-Martin A, Angulo-Diaz-Parreno S, Garcia-Esteo FJ, Mesa-Jimenez JA. Effects of Non-Invasive Neuromodulation of the Vagus Nerve for Management of Tinnitus: A Systematic Review with Meta-Analysis. J Clin Med. 2023 May 25;12(11):3673. doi: 10.3390/jcm12113673. PubMed 37297867 ↗
  • Didier HA, Cappellari AM, Sessa F, Gianni AB, Didier AH, Pavesi MM, Caria MP, Curone M, Tullo V, Di Berardino F, Iacona E, Lilli G, Barozzi S, Alde M, De Bortoli G, Zanetti D, Arnone F, Bussone G. Somatosensory tinnitus and temporomandibular disorders: A common association. J Oral Rehabil. 2023 Nov;50(11):1181-1184. doi: 10.1111/joor.13541. Epub 2023 Jun 28. PubMed 37335244 ↗
  • DE-PAULO, N. F.; HILGENBERG-SYDNEY, P. B. Effect of dry needling on myofascial trigger points of patients with somatosensory tinnitus: case reports. BrJP, São Paulo, v. 9, e202679, 2026.
  • Cook C, Richardson JK, Braga L, Menezes A, Soler X, Kume P, Zaninelli M, Socolows F, Pietrobon R. Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Neck Disability Index and Neck Pain and Disability Scale. Spine (Phila Pa 1976). 2006 Jun 15;31(14):1621-7. doi: 10.1097/01.brs.0000221989.53069.16. PubMed 16778699 ↗
  • de Araujo Cazotti L, Jones A, Roger-Silva D, Ribeiro LHC, Natour J. Effectiveness of the Pilates Method in the Treatment of Chronic Mechanical Neck Pain: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2018 Sep;99(9):1740-1746. doi: 10.1016/j.apmr.2018.04.018. Epub 2018 May 9. PubMed 29752907 ↗
  • CAVALHEIRO, A. S. et al. Zumbido somatossensorial no Brasil: tendências das produções acadêmicas e implicações para os serviços de saúde. Revista Ibero-Americana de Humanidades, Ciências e Educação, [S. l.], v. 12, n. 2, p. 1-17, 2026. Disponível em: https://doi.org/10.51891/rease.v12i2.24354.
  • CAVALHEIRO, A. S. et al. Abordagem combinada no manejo do zumbido: relato de caso com auriculoterapia, técnica manual e aconselhamento fonoaudiológico. Distúrbios da Comunicação, São Paulo, v. 38, n. 2, e74071, 2026. Disponível em: https://doi.org/10.23925/2176-2724.2026v38i2e74071.
  • Castro MM, Quarantini L, Batista-Neves S, Kraychete DC, Daltro C, Miranda-Scippa A. [Validity of the hospital anxiety and depression scale in patients with chronic pain.]. Rev Bras Anestesiol. 2006 Oct;56(5):470-7. doi: 10.1590/s0034-70942006000500005. Portuguese. PubMed 19468593 ↗
  • Campagna CA, Anauate J, Vasconoelos LGE, Oiticica J. Effectiveness of Dry Needling in Bothersome Chronic Tinnitus in Patients with Myofascial Trigger Points. Int Arch Otorhinolaryngol. 2021 Aug 30;26(2):e233-e242. doi: 10.1055/s-0041-1730429. eCollection 2022 Apr. PubMed 35602278 ↗
  • BRUNO, R. S.; GARCIA, M. V. Aconselhamento fonoaudiológico: um formato único e personalizado para sujeitos com zumbido crônico. Distúrbios da Comunicação, São Paulo, v. 33, n. 2, p. 287-298, 2021. Disponível em: https://doi.org/10.23925/2176-2724.2021v33i2p287-298.
  • BRADY, D. et al. Interventions to reduce soreness after dry needling: a systematic review. JOSPT Open, [S. l.], v. 2, n. 3, p. 194-201, 2024. Disponível em: https://doi.org/10.2519/josptopen.2024.0610.
  • Bond C, Lancaster GA, Campbell M, Chan C, Eddy S, Hopewell S, Mellor K, Thabane L, Eldridge S. Pilot and feasibility studies: extending the conceptual framework. Pilot Feasibility Stud. 2023 Feb 9;9(1):24. doi: 10.1186/s40814-023-01233-1. PubMed 36759879 ↗
  • Batts S, Stankovic KM. Tinnitus prevalence, associated characteristics, and related healthcare use in the United States: a population-level analysis. Lancet Reg Health Am. 2024 Jan 6;29:100659. doi: 10.1016/j.lana.2023.100659. eCollection 2024 Jan. PubMed 38269207 ↗
  • Aydogan Z, Ozturk Ozdes N, Kutlu S, Binay Bolat K, Ocak E. Targeting Tinnitus via Masseter Muscle Stimulation: Innovative Pencil-Electrode TENS Therapy for Bruxism-Associated Tinnitus. Brain Behav. 2026 May;16(5):e71443. doi: 10.1002/brb3.71443. PubMed 42050847 ↗
  • Atan T, Atan D, Ozel S. Effectiveness of Kinesio taping in the treatment of somatosensory tinnitus: A randomized controlled trial. Complement Ther Clin Pract. 2020 May;39:101100. doi: 10.1016/j.ctcp.2020.101100. Epub 2020 Jan 21. PubMed 32379629 ↗
  • ARTIOLI, D. P.; TAVARES, A. L. de F.; BERTOLINI, G. R. F. Auriculotherapy: neurophysiology, points to choose, indications and results on musculoskeletal pain conditions: a systematic review of reviews. BrJP, São Paulo, v. 2, n. 4, p. 356-361, 2019.
  • Aroca JP, Cardoso PMF, Favarao J, Zanini MM, Camilotti V, Busato MCA, Mendonca MJ, Alanis LRA. Auricular acupuncture in TMD - A sham-controlled, randomized, clinical trial. Complement Ther Clin Pract. 2022 Aug;48:101569. doi: 10.1016/j.ctcp.2022.101569. Epub 2022 Apr 12. PubMed 35487130 ↗
  • AMERICANO, J. P. et al. Can infrared thermography replace other methods of assessing orofacial pain intensity? Systematic review. BrJP, São Paulo, v. 7, e20240049, 2024.
  • Alghamdi HA, Alwably AA, Alsaad FI, Alghamdi RJ, Faden A. Temporomandibular joint disorders and tinnitus: a systematic review and meta-analysis. BMC Oral Health. 2026 Feb 20;26(1):536. doi: 10.1186/s12903-026-07898-3. PubMed 41721285 ↗

Individual participant data

Plan to share: Undecided — A decision regarding the sharing of individual participant data has not yet been made. The research team will evaluate the feasibility and conditions for data sharing.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jun 2027, 29 months after the start.

Of 133 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 29 months is above that.

Counting every sponsor, half of 151 studies reached it within 17 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 17, 2026
StartActual
Jan 10, 2025
Primary completionEst.
Jun 2027
CompletionEst.
Dec 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941648
Lead sponsor
Universidade Federal de Santa Maria
Responsible party
Andriele dos Santos Cavalheiro (Doctoral Student, Federal University of Santa Maria, Universidade Federal de Santa Maria) — Principal investigator
First posted
Nov 17, 2026
Start date
Jan 10, 2025
Primary completion
Jun 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion